Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

COMPASS Pathways Plc - American Depository Shares (NQ:CMPS)

7.925 -0.065 (-0.81%)
Streaming Delayed Price Updated: 9:44 AM EST, Feb 25, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about COMPASS Pathways Plc - American Depository Shares

News headline image
Compass Pathways: Q1 Earnings Insights ↗
 
Via Benzinga
News headline image
Earnings Preview: Compass Pathways ↗
 
Via Benzinga
News headline image
Psyched: Psychedelics Reimbursement, Amanita Muscaria Boom, $53M Material Breach Lawsuit & More ↗
EXCLUSIVE: AMA Moves Toward Psychedelic Therapy Reimbursement, Filing A Gap In Regulations 
Via Benzinga
News headline image
This Regulatory Change Means Psychedelic Stocks Are One Step Closer to Being a Buy. Here's Why ↗
Another piece of the regulatory puzzle fell into place, but there are plenty more. 
Via The Motley Fool
News headline image
EXCLUSIVE: AMA Moves Toward Psychedelic Therapy Reimbursement, Filing A Gap In Regulations ↗
The American Medical Association (AMA) is expected to issue the first code for psychedelic therapy reimbursement, following Tuesday's approval of a joint application submitted by MAPS PBC and COMPASS... 
Via Benzinga
News headline image
April Psychedelic Drug Stocks Recap: The Ups And Downs ↗
Via Talk Markets
News headline image
Seelos Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
After Falling 60% in 1 Year, Is Atai Life Sciences Stock Still a Buy? ↗
Atai's stock is hurting, but its pipeline is still packed with promising programs. 
Via The Motley Fool
News headline image
Cybin, Mind Medicine Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From April 18, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From April 17, 2023 ↗
 
Via Benzinga
News headline image
5 Short Squeeze Stocks To Watch: Getty Images, PaxMedica, A Mental Health Care Company And More ↗
Potential short squeeze plays gained steam in 2021, continued through 2022, and remain a focus of new traders looking for the next huge move. High short interest and high cost to borrow are among the... 
Via Benzinga
News headline image
Psilocybin Therapy Continues To Show Positive Outcomes For Cancer And Major Depression Disorder ↗
Results from an advanced clinical trial assessing psilocybin-assisted therapy for patients with cancer and Major Depressive Disorder (MDD) conducted by oncology center Sunstone Therapies were published... 
Via Benzinga
News headline image
ATAI Life Sciences, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From April 13, 2023 ↗
 
Via Benzinga
News headline image
EXCLUSIVE: Investing In The Unique Growth Market Of Psychedelics ↗
The global psychedelics market of drugs such as psilocybin, ketamine and LSD is booming and there are plenty of ways to get involved in the space. 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From April 12, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From April 11, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From April 10, 2023 ↗
 
Via Benzinga
News headline image
10 Short Squeeze Candidates: Getty Images Tops List, PaxMedica Rejoins Top Five, MicroStrategy Moves Up And More ↗
Potential short squeeze plays gained steam in 2021 and continued through 2023 with new traders looking for the next huge move. High short interest and high cost to borrow are among the common traits... 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From April 7, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From April 6, 2023 ↗
 
Via Benzinga
News headline image
Compass Pathways, GH Research Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From April 4, 2023 ↗
 
Via Benzinga
News headline image
Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
What To Expect From The Benzinga Psychedelics Capital Conference, The Must-Attend Event For This Emerging Industry ↗
The world of psychedelics is evolving rapidly, and the Benzinga Psychedelics Capital Conference is the premier event for those who want to be part of this exciting journey. 
Via Benzinga
News headline image
5 Short Squeeze Stocks To Watch: Unicycle Therapeutics, Getty Images And More ↗
Potential short squeeze plays gained steam in 2021 and continued through 2022 with new traders looking for the next huge move. High short interest and high cost to borrow are among the common traits... 
Via Benzinga
News headline image
Largest Psychedelic Stocks -3.4% In March ↗
The munKNEE Psychedelic Drug Stocks Index was down 3.4% in March but is still +1.2% YTD. The best news is the continuing high price targets being set by analysts. 
Via Talk Markets
News headline image
Psychedelic Stock Gainers And Losers From March 31, 2023 ↗
 
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.